证券记录 · 已归档季度
ILMN
Illumina, Inc. · Healthcare · Medical - Diagnostics & Research
22被追踪持有人
0Δ持有人
71.58M持有股份
$6.83B报告持仓市值
+1新建仓位
−1清仓
动量输入（同类管理人）： 持有人广度 0.0% · 股份流向 -4.1% · 净新建仓位 0.0% · 公式
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q2 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 162 | +8 | 116.88M | $20.55B | +11 | −4 |
| Q1 2026 | 158 | -5 | 113.90M | $14.03B | +5 | −11 |
| Q4 2025 | 162 | 0 | 124.91M | $16.38B | +2 | −1 |
| Q3 2025 | 23 | -1 | 78.13M | $7.41B | +1 | −3 |
| Q2 2025 | 22 | 0 | 71.58M | $6.83B | +1 | −1 |
| Q1 2025 | 19 | 0 | 39.00M | $3.09B | +1 | −1 |
| Q4 2024 | 19 | 0 | 37.37M | $4.99B | +2 | −2 |
| Q3 2024 | 18 | 0 | 20.75M | $2.70B | +1 | −1 |
| Q2 2024 | 18 | n/a | 22.19M | $2.32B | n/a | n/a |
持有人 · Q2 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 19.36M | n/a | $1.85B | 0.0% | n/c | 1 | SEC ↗ ×21 |
| 2 | Capital World Investors ✦ | 16.65M | -11.9% | $1.59B | 0.2% | ▼ Trim | 5 | SEC ↗ |
| 3 | The Vanguard Group ✦ (被动) | 15.15M | n/a | $1.45B | 0.0% | n/c | 1 | SEC ↗ ×6 |
| 4 | State Street Global Advisors ✦ (被动) | 5.62M | -4.0% | $535.94M | 0.0% | ▼ Trim | 3 | SEC ↗ |
| 5 | AQR Capital Management ✦ | 3.30M | +55.4% | $313.29M | 0.3% | ▲ Add | 5 | SEC ↗ ×8 |
| 6 | Geode Capital Management ✦ (被动) | 2.87M | +0.8% | $272.92M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 7 | PRIMECAP Management ✦ | 1.96M | -17.4% | $186.86M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 8 | Baillie Gifford ✦ | 1.74M | -42.2% | $166.12M | 0.1% | ▼ Trim | 5 | SEC ↗ ×4 |
| 9 | ARK Investment Management ✦ | 1.17M | +30.5% | $111.45M | 0.8% | ▲ Add | 3 | SEC ↗ |
| 10 | Fidelity (FMR) ✦ | 1.13M | n/a | $107.64M | 0.0% | n/c | 1 | SEC ↗ ×5 |
| 11 | Renaissance Technologies ✦ | 1.02M | -6.2% | $97.50M | 0.1% | ▼ Trim | 5 | SEC ↗ |
| 12 | Arrowstreet Capital ✦ | 334.79K | +81.0% | $31.94M | 0.0% | ▲ Add | 3 | SEC ↗ |
| 13 | Duquesne Family Office ✦ | 300.62K | 新增 | $28.68M | 0.7% | New | 1 | SEC ↗ |
| 14 | Norges Bank ✦ (被动) | 239.64K | +218.8% | $22.86M | 0.0% | ▲ Add | 5 | SEC ↗ |
| 15 | Two Sigma Investments ✦ | 228.32K | -50.3% | $21.78M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 16 | Gotham Asset Management ✦ | 148.21K | +133.6% | $14.14M | 0.1% | ▲ Add | 5 | SEC ↗ |
| 17 | Millennium Management ✦ | 121.53K | -63.4% | $11.59M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 18 | T. Rowe Price ✦ | 120.86K | +3.9% | $11.53M | 0.0% | ▲ Add | 5 | SEC ↗ ×2 |
| 19 | Marshall Wace ✦ | 59.65K | +49.0% | $5.69M | 0.0% | ▲ Add | 2 | SEC ↗ ×3 |
| 20 | Wellington Management ✦ | 29.45K | -20.9% | $2.81M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
| 21 | Citadel Advisors ✦ | 26.89K | -91.2% | $2.57M | 0.0% | ▼ Trim | 5 | SEC ↗ |
| 22 | D. E. Shaw & Co. ✦ | 17.83K | -76.3% | $1.70M | 0.0% | ▼ Trim | 5 | SEC ↗ ×2 |
"持仓权重"指该仓位占该管理人13F申报股票组合市值的比例，即持仓信心指标。✦ = 精选管理人。
新增买入方
| Duquesne Family Office | $28.68M | 0.7% |
已清仓
| Icahn Capital | $17.45M | 曾为 0.2% |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 837 持有人, 154.80M 股份, $18.58B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
持有该证券的受追踪机构最常同时持有的其他证券：基于共同持有计数，而非基本面关联。
公开市场买入 (P)
在我们的覆盖窗口内无内部人士公开市场买入记录。
公开市场卖出 (S)
Sep 04
Meister Keith A.
Director · 7.50K 股 · $1.63M
Sep 04
Meister Keith A.
Director · 11.35K 股 · $2.49M
Sep 04
Meister Keith A.
Director · 100.65K 股 · $21.98M
Sep 03
Meister Keith A.
Director · 13.26K 股 · $2.87M
Sep 03
Meister Keith A.
Director · 9.96K 股 · $2.21M
Sep 03
Meister Keith A.
Director · 6.66K 股 · $1.47M
Sep 03
Meister Keith A.
Director · 13.72K 股 · $3.01M
Sep 03
Meister Keith A.
Director · 9.72K 股 · $2.12M
Sep 03
Meister Keith A.
Director · 14.20K 股 · $3.08M
Sep 03
Meister Keith A.
Director · 8.44K 股 · $1.82M
授予、行权及税务代扣代缴在本平台均不计入买入或卖出。 方法论
Oct 07
SC 13G: FMR LLC
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q2 2025 ·
方法论 ·
通过API获取此数据